Urology · Coeur D' Alene, ID
NPI
1346375235
Since 2007
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
980 Ironwood Dr W, Ste 104
Coeur D' Alene, ID, 83814
Phone (208) 667-0621
Groups this clinician bills Medicare through
Medicare paid, 2024
$397K
14,772 services
Medicare patients, 2024
673
Average age 76
Drug cost, 2024
$5.9M
2,033 prescriptions
Company payments, 2025
$1,628
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward D Ellison was code J0585 (injection, onabotulinumtoxina, 1 unit), 3,900 times for 14 patients. In total Edward D Ellison billed 14,772 services in 92 codes, and Medicare paid $397K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 3,900 | 14 | $4.99 | $19K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 3,770 | 14 | $2.12 | $8,007 |
| J0897 Injection, denosumab, 1 mg | Office | 2,220 | 24 | $19.36 | $43K |
| 99215 Office E&M - Established | Office | 483 | 318 | $126.12 | $61K |
| 87150 Infectious Agent Detection by DNA/RNA | Office | 431 | 38 | $34.39 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 372 | 281 | $11.98 | $4,458 |
| 81001 Clinical Chemistry | Office | 363 | 210 | $3.07 | $1,113 |
| 99214 Office E&M - Established | Office | 311 | 267 | $78.75 | $24K |
| 81003 Clinical Chemistry | Office | 285 | 215 | $2.17 | $619 |
| 51798 Ultrasound - Nonspecific | Office | 158 | 114 | $7.85 | $1,240 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 156 | 12 | $34.39 | $5,365 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 138 | 14 | $43.25 | $5,969 |
| 52000 Cystourethroscopy | Office | 132 | 100 | $168.01 | $22K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 131 | 13 | $34.47 | $4,515 |
| 99205 Office E&M - New | Office | 99 | 99 | $142.38 | $14K |
By year: 2022 $528K for 15,409 services; 2023 $617K for 13,402 services; 2024 $397K for 14,772 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87150 Infectious Agent Detection by DNA/RNA | 431 | 38 | $34.39 | $15K |
| 81001 Clinical Chemistry | 363 | 210 | $3.07 | $1,113 |
| 81003 Clinical Chemistry | 285 | 215 | $2.17 | $619 |
| 87798 Infectious Agent Detection by DNA/RNA | 156 | 12 | $34.39 | $5,365 |
| 87500 Infectious Agent Detection by DNA/RNA | 41 | 38 | $34.39 | $1,410 |
| 87481 Infectious Agent Detection by DNA/RNA | 39 | 12 | $34.39 | $1,341 |
| 87640 Infectious Agent Detection by DNA/RNA | 13 | 12 | $34.39 | $447 |
| 87641 Infectious Agent Detection by DNA/RNA | 13 | 12 | $34.39 | $447 |
| 87651 Infectious Agent Detection by DNA/RNA | 13 | 12 | $34.39 | $447 |
| 87653 Infectious Agent Detection by DNA/RNA | 13 | 12 | $34.39 | $447 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward D Ellison prescribed most often to Medicare patients was Orgovyx (Relugolix), with 526 prescriptions and refills. In total Edward D Ellison wrote 2,033 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 526 | 526 | 56 | $1.4M |
| Tamsulosin Hcl Generic | 386 | 942 | 132 | $6,400 |
| Xtandi Enzalutamide | 250 | 250 | 27 | $3.4M |
| Gemtesa Vibegron | 109 | 131 | 25 | $60K |
| Prednisone Generic | 103 | 107 | 11 | $316 |
| Abiraterone Acetate Generic | 88 | 88 | Under 11 | $160K |
| Myrbetriq Mirabegron | 81 | 135 | 19 | $59K |
| Finasteride Generic | 81 | 230 | 26 | $1,320 |
| Erleada Apalutamide | 46 | 46 | Under 11 | $641K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 39 | 34 | $189 |
| Oxybutynin Chloride Generic | 34 | 46 | 27 | $772 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 24 | 41 | 11 | $282 |
| Ciprofloxacin Hcl Generic | 21 | 21 | 21 | $159 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 18 | 32 | Under 11 | $2,897 |
| Silodosin Generic | 17 | 45 | Under 11 | $1,279 |
Brand drugs: 1,033 claims; generic drugs: 1,000 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward D Ellison $1,628 ($1,628 in general payments such as food, travel and fees) from 19 companies. The largest payer was Janssen Biotech, Inc. with $319.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $319 |
| Astellas Pharma US Inc 4503.T | 9 | $271 |
| Sumitomo Pharma America, Inc. 4506.T | 9 | $228 |
| Dendreon Pharmaceuticals LLC | 5 | $130 |
| Bluewind Medical | 1 | $66.45 |
| Olympus America Inc. | 3 | $64.56 |
| Accord Healthcare, Inc. | 3 | $63.35 |
| Endo USA, Inc. | 2 | $62.34 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $61.8 |
| Immunitybio, Inc. IBRX | 3 | $59.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.